Company intelligence / Profile preview

Acclarent

Irvine, California, United Statesintegralife.com ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

Acclarent has pioneered minimally invasive technologies in the ENT field. Its Balloon Sinuplasty system has been used in over half a million procedures. The ACCLARENT AERA™ system was the first FDA-approved balloon dilation device to treat Eustachian Tube Dysfunction at its source, showing high technical success rates (~99.7%) and significant improvement in patient outcomes with no serious adverse events reported. The company also recently launched an AI-powered navigation platform to assist surgeons during complex ENT procedures.

Therapeutic areas: OtherOtolaryngologyPulmonology
Modalities: Minimally invasive medical devices (not drugs or biologics)
Industry: Surgical Medical Devices

Drug pipeline

1 asset

Relieva Stratus Microflow Spacer

Commercial

Indications: Sinus conditions

Partnerships

Previously part of Johnson & Johnson MedTech/Ethicon before acquisition by Integra LifeSciences

Beyond the preview

Go deeper on Acclarent.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acclarent.

Explore the full profile